Form 4 for BFRI Biofrontera Inc.
Accepted 2023-05-22 00:00:00 ET · period of report 2023-05-18 · accession 0001493152-23-018643 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-22 | 2023-05-18 | BFRI | Monaco Erica L. | CEO | M - OptEx | — | +76.3K | 133.0K | +135% | — |
| D | 2023-05-22 | 2023-05-18 | BFRI | Monaco Erica L. | CEO | M - OptEx | $0.00 | -76.3K | 76.3K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-18 | M | A | 76,336 | — | 133,025 | D | — | — | (F1) Restricted stock units covert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2023-05-18 | M | D | 76,336 | $0.00 | 76,336 | D | — · — to — | 76,336 Commom Stock | (F1) Restricted stock units covert into common stock on a one-for-one basis. (F2) On May 18, 2022, the reporting person was granted 152,672 restricted stock units, vesting in two equal annual installments beginning on May 18,2023. |